OXIGENE, INC.

Company

Oncotelic Therapeutics, Inc.

Filed

May 15, 2009

Period of Report

March 31, 2009

Accession Number

0000950135-09-004064

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →